Search PubMed⌕ Search

Biomedical subjects

C A May

Publications and source records attributed to C A May.

39 records · Page 3Linked to original sources

Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose.

A mathematical equation that predicts the maintenance dose needed to achieve a desired steady-state plasma concentration (Css) for first-order drugs from a single plasma concentration drawn after a single dose was tested for valproic acid. Six healthy volunteers received a single oral 500-mg dose of valproic acid and plasma concentrations were determined at 0, 1, 2, 4, 6, 8, 10, 24, and 32 hours. Each subject then received 750 mg of valproic acid daily in three divided doses for four days and a Css was determined. The equation was rearranged to predict the Css of valproic acid from plasma concentrations drawn at 1, 2, 4, 6, 8, and 10 hours after the single dose of valproic acid, using individually determined and mean terminal rate constant (k) values. The predicted Css were then compared with the actual Css. There was no difference in the predicted and actual Css using plasma concentrations collected at 6, 8, or 10 hours regardless of the derivation of the k values. The four-hour concentration predicted a lower Css if the mean (rather than the individual) k values were used. The one- and two-hour concentrations were not accurate predictors. While a 6-, 8-, or 10-hour plasma concentration would be adequate for predicting the Css, the 10-hour concentration had the least difference between the predicted and actual values. The time and cost of titrating valproic acid to a desired Css may be decreased by using this mathematical equation to predict the necessary maintenance dose.

Adult↗

Effects of three antacids on the bioavailability of valproic acid.

The effects of three antacid products on the bioavailability of valproic acid were evaluated. Each of seven normal, healthy volunteers received a 500-mg dose of valproic acid alone on one occasion and then with each of three commonly used antacids. Specifically, equal neutralizing capacity doses of 160 meq of Maalox (62 ml), Trisogel (97 ml), or Titralac (42 ml) were administered one and three hours after meals and at bedtime on the same day. Blood samples were obtained at 0, 1, 2, 4, 6, 8, 10, 24, and 32 hours and analyzed for valproic acid by gas liquid chromatography. There was a significant increase in total area under the curve (AUC) (range 3% to 28%, mean 12%) when valproic acid was administered with Maalox (p = 0.026 for total AUC and p = 0.009 for AUC to 32 hours). There was an insignificant trend toward an increase in AUC when valproic acid was administered with the other two antacids. No differences were observed in time to peak serum concentration, height of peak serum concentration, volume of distribution, half-life, or first order elimination rate constant. Caution should be exercised if valproic acid and antacids are administered concomitantly.

Adult↗